What this study is
This study aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a Multiple-level intervention integrating lung cancer screening and smoking cessation (MILS), followed the NIH DEIA strategies using multilevel interventions that impact determinants of health and address health disparities at appropriate time points across the life course.
What's being tested
- Smoking cessation multilevel Intervention
Intervention · BEHAVIORAL
The intervention will utilize a multilevel intervention based on the Social Ecological Model's individual, institutional, and community levels.
Study details
- Official title
- Effectiveness of a Multilevel Integrated Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans
- Sponsor
- Louisiana State University Health Sciences Center in New Orleans
- Conditions
- Lung Cancer Screening · Tobacco Use Disorder · Smoking Cessation
- Enrolling
- 250 people
- Starts
- 2025-04-17
- Est. completion
- 2030-06
- Design
- Open-label, randomized, sequential groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 50 Years – 80 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- African American
- 20+ pack years of smoking
- Eligible for or received LDCT screening
- Current smoker
- English speaking
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (2)
2 openLSUHSC School of Public Health
New Orleans, Louisiana, United States
RecruitingUniversity Medical Center
New Orleans, Louisiana, United States
Recruiting
Study team
Sponsor
Louisiana State University Health Sciences Center in New Orleans
Study ID 7750
Principal investigator
Tung Sung Tseng, DrPH, MS
LSUHSC New Orleans
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.